Kymera Therapeutics
KYMR
#3504
Rank
ยฃ2.42 B
Marketcap
ยฃ37.51
Share price
3.80%
Change (1 day)
222.36%
Change (1 year)

Kymera Therapeutics (KYMR) - P/B ratio

P/B ratio as of November 2024 : 3.51

According to Kymera Therapeutics's latest financial reports the company has a price-to-book ratio of 35.8246.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Kymera Therapeutics - P/B ratio (from 2020 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-31N/A-100%
2023-12-313.5828.02%
2022-12-312.79-60.64%
2021-12-317.10-26.9%
2020-12-319.71
2019-12-31N/A

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
2.13-39.24%๐Ÿ‡บ๐Ÿ‡ธ USA